Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2016 / Cilt: 56 - Sayı: 3

TWO CASES WITH BENIGN TRANSIENT HYPERPHOSPHATEMIA

GEÇİCİ BENİGN HİPERFOSFATAZEMİLİ İKİ OLGU

Pages
201–204
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patient can also be followed up in general pediatric clinics without referring to another center and performing unnecessary, richer tests.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bening transient hyperphosphatasemia is a clinic status seen in children generally youn ger than 5 years and characterized by serum alkaline phosphate (ALP) level higher than 3-50 times above the normal without evidence of liver and bone disease.
📊
Key Findings & Data:The high alkaline phosphates level turn normal in 2-6 month.
💡
Conclusion & Impact:Patient can also be followed up in general pediatric clinics without referring to another center and performing unnecessary, richer tests.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bening transient hyperphosphatasemia is a clinic status seen in children generally youn ger than 5 years and characterized by serum alkaline phosphate (ALP) level higher than 3-50 times above the normal without evidence of liver and bone disease. The high alkaline phosphates level turn normal in 2-6 month. This article presents two cases that diagnosed elevated alkaline phosphate levels during routine tests, turn to normal spontaneously and had no liver and bone diseases. It is thought that this high level is due to viral infection. Benign transient hyperphosphatasemia is a condition that benign, transient and self limited. In the event of isolated high levels of ALP without clinical and laboratory findings, transient hyperphosphatasemia should be considered in the differential diagnosis. Patient can also be followed up in general pediatric clinics without referring to another center and performing unnecessary, richer tests.

Özet

Benign geçici hiperfosfatazemi çoğunlukla 5 yaşından küçük çocuklarda serum alkalen fosfataz düzeyinin karaciğer ve kemik hastalığı olmaksızın normal değerlerin 3-50 kat yükselmesiyle karakterize bir klinik durumdur. Alkalen fosfataz düzeyleri 2-6 ay içinde kendiliğinden normale dönmektedir. Bu yazıda rutin tetkikler sırasında ALP düzeyinde yükseklik saptanan, takiplerinde kendiliğinden normale dönen, karaciğer ve kemik hastalığı bulunmayan ve bu yüksekliğin sebebinin viral enfeksiyonlara bağlı benign geçici hiperfosfatazemi olduğu düşünülen iki olgu sunulmuştur. Benign geçici hiperfosfatazemi benign, geçici ve kendini sınırlayabilen bir durumdur. Klinik ve laboratuar bulgusu olmadan izole ALP yüksekliği durumunda, geçici hiperfosfatemi ayırıcı tanıda mutlaka akılda tutulmalıdır. Bu hastalar gereksiz ve pahalı testlere gerek kalmadan ve ileri bir merkeze sevk edilmeden genel çocuk polikliniklerinde izlenebilirler.

🔖

Cite This Article

YAŞAR, A., AKYÜZ, E. Ö., HÜSREVŞAHİ, H., GEÇİT, U. A. (2022). TWO CASES WITH BENIGN TRANSIENT HYPERPHOSPHATEMIA. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 56 - Sayı: 3, 201–204. https://ajindex.com/articles/535276

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Crofton PM. What is the cause of benign transient hy- perphosphatasemia ? A study of 35 cases. Clin Chem 1988;34(2):335-40. Tolaymat N, de Melo MC. Benign transient hyperp- hosphatasemia of infancy and childhood. South Med J 2000;93(12): 1162-4.
  2. Candemir M, Özdemir MA, Ergin H. [A Case of Be- nign Transient Hyperphosphatasemia]. Fırat Tıp Derg 2008;13(1):74-6.
  3. Suzuki M, Okazaki T, Nagai T, Toro K, Setonyi P. Viral infection of infants and children with benign transient hyperphosphatasemia. FEMS Immunol Med Microbiol 2002;33(3): 215-8.
  4. Kraut JR, Metrick M, Maxwell NR, Kaplan MM. Isoenz- yme studies in transient hyperphosphatasemia of infan- cy. Ten new cases and a review of the literature. Am J Dis Child 1985;139(7):736-40. Chesney WR. Metabolic bone disease In: Behrman RE, Kliegman RM, JJenson HB eds. Nelson Textbook of Pe- diatrics 17 th edition. WB. Saunders Company, Phile- delphia USA 2004: 2341-8. Arman D. [İnfeksiyoz Mononükleoz]. In: Wilke Topçu A, Söyletir G, Doğanay M, editors. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. Nobel Tıp Kitabevleri. 7nd Ed. İstan- bul, 2008, 696-701.
  5. Watanabe S, Arima K, Nishioka M, Yoshino S, Hasui H, Fujikawa M. Comparison between sporadic cytomega- lovirus hepatitis and Ebstein-Barr virus hepatitis in pre- viously healty adults. Liver 1997;17(2):63-9.